Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease

被引:65
|
作者
Ahlskog, JE [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
关键词
Parkinson's disease; oxidative stress; dopamine; levodopa;
D O I
10.1002/mds.20362
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Oxidative stress is well documented in Parkinson's disease (PD) and has been attributed to dopamine oxidative metabolism. However, evidence of oxidative stress is found in a variety of neurodegenerative disorders, suggesting that more general factors are responsible or that cytodestructive processes secondarily generate oxyradical products. Increasing evidence points away from dopamine metabolism as an important contributor to PD neurodegeneration. Predictions front the dopamine oxidative stress hypothesis of PD reveal multiple inconsistencies. Although the clinical and therapeutic importance of the nigrostriatal dopaminergic system is undeniable, PD neuropathology is much more widespread. (c) 2004 Movement Disorder Society.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 50 条
  • [31] Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease
    Kumar, Shobhit
    Dang, Shweta
    Nigam, Kudeep
    Ali, Javed
    Baboota, Sanjula
    REJUVENATION RESEARCH, 2018, 21 (05) : 464 - 476
  • [32] Evidence of a Role for the TRPC Subfamily in Mediating Oxidative Stress in Parkinson's Disease
    Maria-Ferreira, Daniele
    Turin de Oliveira, Natalia Mulinari
    Malaquias da Silva, Liziane Cristine
    Fernandes, Elizabeth Soares
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [33] Role of Oxidative Stress in the Etiology of Parkinson's Disease: Advanced Therapeutic Products
    Lavrova, A. V.
    Gretskaya, N. M.
    Bezuglov, V. V.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2021, 47 (05) : 980 - 996
  • [34] Role of Oxidative Stress in the Etiology of Parkinson’s Disease: Advanced Therapeutic Products
    A. V. Lavrova
    N. M. Gretskaya
    V. V. Bezuglov
    Russian Journal of Bioorganic Chemistry, 2021, 47 : 980 - 996
  • [35] Dopamine agonists: their role in the treatment of Parkinson's disease
    Brooks, DJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (06): : 685 - 689
  • [36] Role of dopamine agonists in Parkinson's disease therapy
    D. Woitalla
    C. Buhmann
    R. Hilker-Roggendorf
    G. Höglinger
    J. Koschel
    T. Müller
    D. Weise
    Journal of Neural Transmission, 2023, 130 : 863 - 873
  • [37] The role of dopamine agonists in early Parkinson's disease
    Watts, RL
    NEUROLOGY, 1997, 49 (01) : S34 - S48
  • [38] Hypersexuality and Parkinson's disease: The role of dopamine replacement
    Klos, KJ
    Bower, JH
    Josephs, KA
    Matsumoto, JY
    Ahlskog, JE
    MOVEMENT DISORDERS, 2005, 20 : S54 - S54
  • [39] The role of inflammation and dopamine synthesis in Parkinson's disease
    Ong, L. K.
    Briggs, G. D.
    Dunkley, P. R.
    Dickson, P. W.
    JOURNAL OF NEUROCHEMISTRY, 2014, 130 : 40 - 40
  • [40] Dopamine agonists - Their role in the management of Parkinson's disease
    Rascol, O
    Ferreira, JJ
    Thalamas, C
    Galitsky, M
    Montastruc, JL
    PARKINSON'S DISEASE, 2001, 86 : 301 - 309